Showing 261 - 280 results of 39,308 for search '(( 5 non decrease ) OR ( 50 ((((mean decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.20s Refine Results
  1. 261

    mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

    Published 2020
    “…(<b>B</b>) <i>FIP200</i> and <i>ATG101</i> mRNA expressions were decreased in the primary cultured podocytes from <i>Tsc2</i><sup>Δ<i>podocyte</i></sup>. …”
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267

    Transient neonatal olfactory deprivation causes a persistent decrease in the addition of CR+ PGCs. A by Yasuko Kato (122938)

    Published 2012
    “…The numbers of all three types of cells were significantly decreased by the 8<sup>th</sup> week of naris occlusion (<b>C</b>, red bars, <i>n</i> = 4) compared with the control group (<b>C</b>, blue bars, <i>n</i> = 5). …”
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279

    Cellular input resistance is decreased during UP states. by Brendon O. Watson (268774)

    Published 2008
    “…Mean decrease was 50.9%; standard deviation was 36.6%, shown in gray bar at left. 2 of 4 interneurons showed significant decreases in resistance during the UP state and one cell actually showed an increase. …”
  20. 280

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”